Search：
All Dates：
- All
- 2026-06-11 [Thursday]
- 2026-06-12 [Friday]
- 2026-06-13 [Saturday]
- 2026-06-14 [Sunday]
All Rooms：
- All
- A1-A (102-107)
- A1-A101
- A1-A102
- A1-A103
- A1-A104
- A1-A (105-107)
- A1-A108
- A1-A109
- A1-A110
- A2-A206
- A2-A207
- A2-A208
- A2-A213
- A2-A214
- A2-A215
- B1 Hall (Poster Area)
- B1 Hall (Exhibition Area)
2026-06-13 (Saturday)
A1-A108
08:00-09:30
| The combination with TKI/immunotherapy and the INSPIRE initiative with selective approach
| NO. | Time | Presentation Topic | Speaker | Affiliation / Organization |
|---|---|---|---|---|
| 1 | 08:00-08:05 |
Welcome & Opening Remarks |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 2 | 08:05-08:25 |
Super Selective cTACE in HCC: Asian Expertise, Standardization, and Its Role in Modern Treatment Algorithms |
Yozo Sato | Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan |
| 3 | 08:25-08:45 |
Why cTACE–Based Combination Strategies Matter in the Era of TKIs and Immunotherapy ? |
David C. Madoff | Yale School of Medicine, USA |
| 4 | 08:45-09:05 |
Evaluating cTACE in the Chinese HCC Treatment Paradigm: Rationale for Multimodal Combination and Conversion Strategies |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 5 | 09:05-09:30 |
Panel discussion |
David C. Madoff | Yale School of Medicine, USA |
| 6 | 09:05-09:30 |
Panel discussion |
Xiao-Li Zhu | The First Affiliated Hospital of Soochow University, China |
| 7 | 09:05-09:30 |
Panel discussion |
Yozo Sato | Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan |
